Insights

Decentralized Trial Focus Curebase's strong emphasis on democratizing clinical trials through decentralized and virtual study models presents a significant opportunity to target healthcare organizations and research sponsors looking to expand patient access and reduce trial costs.

Strategic Partnerships Recent collaborations with Walgreens and integration with Redenlab demonstrate Curebase’s ability to partner with large healthcare providers and technology platforms, suggesting potential for further alliances with pharmaceutical companies and health systems seeking scalable trial solutions.

Funding & Growth With a recent $40 million funding round and a revenue range of $1M to $10M, Curebase is positioned for growth and expansion of its tech platform, opening opportunities to cross-sell integrated software solutions and clinical trial management services.

Tech-Enabled Differentiation Curebase’s utilization of AI-driven tools and HIPAA-compliant integrations indicates a focus on secure, innovative technology, appealing to enterprise clients in need of reliable, cutting-edge eClinical software for modern trials.

Market Positioning As a smaller, agile competitor in the clinical trial software space, Curebase can differentiate by targeting niche markets such as at-home COVID-19 vaccine trials and diverse population enrollment, offering tailored solutions for sponsors prioritizing patient-centric and inclusive research.

Curebase Tech Stack

Curebase uses 8 technology products and services including Bing Ads, Linkedin Insight Tag, Cloudflare, and more. Explore Curebase's tech stack below.

  • Bing Ads
    Advertising Networks
  • Linkedin Insight Tag
    Analytics
  • Cloudflare
    Content Management System
  • OneTrust
    Cookie Compliance
  • Google Fonts API
    Font Scripts
  • Atlassian Jira
    Issue Trackers
  • shadcn/ui
    UI Frameworks
  • Tailwind CSS
    UI Frameworks

Media & News

Curebase's Email Address Formats

Curebase uses at least 2 format(s):
Curebase Email FormatsExamplePercentage
First@curebase.comJohn@curebase.com
52%
First.Last@curebase.comJohn.Doe@curebase.com
35%
Last@curebase.comDoe@curebase.com
8%
FirstLast@curebase.comJohnDoe@curebase.com
4%
FiLast@curebase.comJoDoe@curebase.com
1%

Frequently Asked Questions

Where is Curebase's headquarters located?

Minus sign iconPlus sign icon
Curebase's main headquarters is located at San Francisco, California United States. The company has employees across 5 continents, including North AmericaSouth AmericaAsia.

What is Curebase's official website and social media links?

Minus sign iconPlus sign icon
Curebase's official website is curebase.ai and has social profiles on LinkedInCrunchbase.

What is Curebase's NAICS code?

Minus sign iconPlus sign icon
Curebase's NAICS code is 5112 - Software Publishers.

How many employees does Curebase have currently?

Minus sign iconPlus sign icon
As of March 2026, Curebase has approximately 50 employees across 5 continents, including North AmericaSouth AmericaAsia. Key team members include Chief Executive Officer: S. S.Chief Operating Officer: S. S.Vice President Of Operations & Strategy: B. S.. Explore Curebase's employee directory with LeadIQ.

What industry does Curebase belong to?

Minus sign iconPlus sign icon
Curebase operates in the Software Development industry.

What technology does Curebase use?

Minus sign iconPlus sign icon
Curebase's tech stack includes Bing AdsLinkedin Insight TagCloudflareOneTrustGoogle Fonts APIAtlassian Jirashadcn/uiTailwind CSS.

What is Curebase's email format?

Minus sign iconPlus sign icon
Curebase's email format typically follows the pattern of First@curebase.com. Find more Curebase email formats with LeadIQ.

How much funding has Curebase raised to date?

Minus sign iconPlus sign icon
As of March 2026, Curebase has raised $40M in funding. The last funding round occurred on May 05, 2022 for $40M.

When was Curebase founded?

Minus sign iconPlus sign icon
Curebase was founded in 2017.

Curebase

Software DevelopmentCalifornia, United States11-50 Employees

Curebase is reimagining clinical research by building the AI-native eClinical platform that serves sponsors and sites on a single unified system, giving sites modern technology, sponsors pristine data, and ultimately supporting the acceleration of breakthrough treatments for patients.

Our platform includes advanced recruitment, compliance monitoring, data capture, ePRO, eConsent, EDC, and participant engagement all powered by Hope, our Voice AI Agent woven throughout the entire system.

With Sitebase, we offer FREE CTMS, eISF, and eSource technology to clinical research sites, giving them access to the same cutting-edge tools larger organizations use, without worrying about cost.

We're solving a fundamental industry imbalance: research sites deserve modern technology without financial barriers, and sponsors deserve pristine data quality that comes from tech that sites and patients actually like to use.

When sites have technology they actually enjoy using, everyone wins: sponsors get complete, error-free data, sites can focus on patient care, and patients get better clinical trial experiences that bring breakthrough treatments to market faster.

Research. Reimagined.

Section iconCompany Overview

Headquarters
San Francisco, California United States
NAICS Code
5112 - Software Publishers
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $40M

    Curebase has raised a total of $40M of funding over 5 rounds. Their latest funding round was raised on May 05, 2022 in the amount of $40M.

  • $10M$25M

    Curebase's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $40M

    Curebase has raised a total of $40M of funding over 5 rounds. Their latest funding round was raised on May 05, 2022 in the amount of $40M.

  • $10M$25M

    Curebase's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.